💊 GLP-1 startup opportunities for consumer founders

The best consumer founders know the game. 30K+ of them read Consumer Startups every week.

Stay ahead. Get the playbook behind today's breakout startups.

Read time: 4 mins 52 seconds

A drug originally designed to manage blood sugar is quietly reshaping every consumer category.

Fashion. Fashion. Beauty. Alcohol. Fitness. Dating. Grocery. And of course, health.

That drug is GLP-1.

Nearly one in five US adults have tried this drug and one in eight say they are currently taking it. 

I’ve personally seen many people around me start taking GLP-1s. I had the chance to interview several of them and was fascinated by the impact it’s having on their body, behavior, identity, and mindset.

Over this past weekend, I started brainstorming some consumer startup ideas that take advantage of this consumer trend. 

Excited to share them with y’all today.

GLP-1 stands for glucagon-like peptide-1. It is a hormone your gut naturally releases when you eat to tell your brain "I'm full." These drugs (Ozempic, Wegovy, Mounjaro, etc) were originally designed to treat type 2 diabetes by helping regulate blood sugar. Recently, doctors noticed patients were losing a ton of weight. Now millions of people are taking them primarily for weight loss. 

The market numbers are bonkers. Goldman Sachs estimates $100-150 billion by 2030. Oral versions (no more needles) were approved just a few months ago. This unlocked mass market adoption. 

However, the drug itself is likely not the opportunity for most founders. The opportunity is everything that changes downstream when millions of people simultaneously rewire their relationship with food, alcohol, and their own bodies.

GLP-1 does not just kill your appetite. It blunts the brain's dopamine reward pathways. People are reporting they lost interest in alcohol, gambling, compulsive shopping, even nail biting. One patient described it as feeling like "a valve was turned off."

I think about the startup opportunities here as a cascade.

The drug changes your body. Your body changes your behavior. Your behavior changes your identity. Each stage of that cascade creates consumer startup opportunities.

I have grouped the opportunities into three big buckets.

GLP-1 is incredibly effective at weight loss. Maybe too effective. The body loses weight fast but it does not always lose the right kind of weight. 

When I talked to friends on GLP-1, the complaints were generally consistent. Losing muscles. Nausea. Feeling weak. Skin looking off. Hair thinning. Your body is screaming for nutrients it is not getting because you went from eating 2,500 calories to <1,500. 

20-35% of weight lost on GLP-1 comes from muscle, not fat. That is a LOT of muscle. This creates a chain reaction of problems. There are new ways to mitigate that through compound medicine, such as taking GLP-1 with bimagrumab. However, there will still be massive needs around supplementing the nutrient loss.

1/ "Easy stomach" protein brand

GLP-1 users desperately need protein to preserve muscle. Steak and large chicken breasts are going to be hard for GLP-1 users to stomach so many have turned to protein shakes. 

However, GLP-1 slows gastric emptying, which means thick shakes just sit in your stomach and make you nauseous.

Dietitians are now telling patients to ditch the creamy shakes entirely. Go for clear, juice-like protein drinks. 

Another opportunity is in the flavor profile. 26% find protein supplements too sweet, and 37% are actively hunting for savory protein alternatives like broths and jerky, according to a study done by Listen Labs. There are opportunities here.

2/ The AG1 of GLP-1 supplements

The supplement needs are clinically documented: protein + HMB for muscle, creatine for strength, vitamin D + calcium for bone density, B12 for energy, fiber + probiotics for the lovely GI side effects, electrolytes for hydration.

That is like six different products. Nobody has put them into one system.

The winner builds the AG1 playbook. One simple scoop with everything you need, formulated by a doctor. Subscription model :)

3/ Affordable "Ozempic face" skincare

The weight comes off fast, but the face changes fast too. Most common symptoms are sagging skin and sunken cheeks. 

It has its own name now: "Ozempic face."

Current products are expensive. Image Skincare's VOL.U.LIFT runs $134. DermaReverse is $300. This price point is okay for the Equinox crowd but not so great for the millions of people who will be on these drugs by 2030.

The white space is an affordable DTC skincare brand for post-weight-loss skin. Somebody is going to build the CeraVe of Ozempic face soon.

GLP-1 also rewires how you eat, drink, and spend your time.

My friends on GLP-1 all say some version of the same thing: “I just… don’t want it anymore.” GLP-1 also seems to reduce impulsive urges around alcohol, snacks, late-night shopping, and other addictions.

44% of users drink less alcohol AND 82% keep that habit even after stopping the drug. Dining out spending drops 8.6%. Snack sales are down ~10% among users.

A whole generation of consumer brands were built on impulse, indulgence, and "treat yourself”. GLP-1 is the anti-thesis. The founders who understand this shift will build the next wave.

1/ GLP-1 meal kit

Nestle launched Vital Pursuit. Major UK retailers like Morrison launched meals for smaller appetites. However, no startup owns the GLP-1 meal kit. 

I see an opportunity to build a HelloFresh for GLP-1 meal kit: high-protein, smaller portions, nutrient-dense, and gentle on the stomach.

2/ Functional "social drinks" brand

GLP-1 users still want the social ritual of drinking. They just don't want the alcohol. The drug dampens the dopamine reward from booze. One researcher described it as a shift from "habitual" to "intentional" consumption.

There are opportunities building around functional social drinks. Sophisticated flavors with beautiful bottles. Adaptogens or nootropics for a mood lift without the hangover. Position for the evening ritual that GLP-1 users want but cannot find. 

3/ Sober social experiences platform

Related but a different angle.

Only half of 18-34 year olds drank alcohol in 2025. Down from 60% two years earlier. GLP-1 is the biological accelerant to an already massive sober curious movement.

There could be an opportunity for a platform focused on alcohol-free social experiences. Activity-based hangouts for people who want connection without centering it around a bar. 

The TAM here is an entire generation that’s drinking less, not just GLP-1 users.

4/ GLP-1 Fitness App

Everybody tells GLP-1 users to strength train to preserve muscle. Except many GLP-1 users are nauseous, low energy, and often have not touched a weight in years.

17 fitness operators have launched GLP-1 programs. However, I haven’t seen any dominant standalone consumer app for this user. Progressive resistance training. Recovery focused. Protein timing baked into nutrition tracking. Workouts designed for someone who might throw up if they push too hard on day one. 

The new you means a new identity.

GLP-1 users are rebuilding their wardrobes, their social circles, and their self-image. 80% anticipate needing new clothing. 46% are experimenting with styles they never would have tried before. Thrift spending surged 80%. 

Lurking behind all of this is the maintenance problem. Half of patients stop within a year. When they do, the weight comes back fast. 82% regain 25%+ within a year of stopping. Stop abruptly and you can regain 50-80%.

That means every product in this space needs to think about the long game. Not just the weight loss phase.

1/ Transitional wardrobe subscription

The average GLP-1 user stays on for about 7 months. Might drop 2-4 sizes. A subscription that sends a new wardrobe box as your size changes and takes back the old one. Rent the Runway meets weight-loss journey. 

2/ Weight-Loss Wardrobe Resale Platform

People donating larger sizes and buying smaller ones. One person’s old size is another’s new size. A resale platform built for this transition has a natural two-sided flywheel baked right in. I see a vertical Poshmark play here.

3/ GLP-1 Journey App

64% of patients discontinue within year one. The adherence problem is massive. 

Track injections, dose changes, side effects, weight, body composition, nutrition, hydration. All in one app. 

There are some small players in the market like Shotsy but no one dominates. WeightWatchers is trying but carries too much legacy baggage. There’s room for more modern players to compete and serve this segment.

4/ GLP-1 Community Platform

Reddit's r/Ozempic pulls 62K+ weekly visitors. Demand for community is massive, but fragmented. There's an opening to build a dedicated platform: support groups, before-and-afters, product reviews, doctor Q&As, and a curated marketplace.

There is an interesting data play here as well. You'd know exactly what GLP-1 users are buying, struggling with, and recommending. The community becomes the distribution channel for every GLP-1-adjacent brand.

Community + marketplace + data flywheel.

I think GLP-1 could have a bigger impact on society than even AI.

Unlike past health trends like keto and paleo, GLP-1 is more biologically driven and can physically rewire your brain to resist cravings for food, alcohol, and more.

It’s also a rare trend that hits nearly every consumer category at once: food, beverage, fitness, fashion, beauty, social, and more. And many of the second-order effects seem to stick.

With the recent approval of oral GLP-1 medications, the TAM is only going to grow.

Excited to see how this space plays out. If you’re building in any of the verticals I mentioned, hit me up!

See you next Tuesday,

Leo

Follow me on X and LinkedIn

📥️ Want to advertise in Consumer Startups? Learn more.